Dishman Carbogen [DCAL] vs Til [TIL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Dishman Carbogen Amcis Ltd. wins in 8 metrics, Til Ltd. wins in 3 metrics, with 0 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dishman Carbogen Amcis Ltd. | Til Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.30 | 26.18 | Dishman Carbogen Amcis Ltd. |
| Price-to-Book Ratio | 0.42 | 3.22 | Dishman Carbogen Amcis Ltd. |
| Debt-to-Equity Ratio | 40.20 | N/A | N/A |
| PEG Ratio | -0.16 | 2.42 | Til Ltd. |
| EV/EBITDA | 9.62 | 18.17 | Dishman Carbogen Amcis Ltd. |
| Profit Margin (TTM) | 4.25% | 9.68% | Til Ltd. |
| Operating Margin (TTM) | 3.99% | N/A | N/A |
| EBITDA Margin (TTM) | 3.99% | N/A | N/A |
| Return on Equity | 0.06% | N/A | N/A |
| Return on Assets (TTM) | 0.03% | N/A | N/A |
| Free Cash Flow (TTM) | $1.58B | $-1.37B | Dishman Carbogen Amcis Ltd. |
| 1-Year Return | -33.95% | -49.35% | Dishman Carbogen Amcis Ltd. |
| Price-to-Sales Ratio (TTM) | 0.95 | 9.94 | Dishman Carbogen Amcis Ltd. |
| Enterprise Value | $46.55B | $104.86B | Til Ltd. |
| EV/Revenue Ratio | 1.66 | 1.93 | Dishman Carbogen Amcis Ltd. |
| Gross Profit Margin (TTM) | 80.34% | 57.53% | Dishman Carbogen Amcis Ltd. |
| Revenue per Share (TTM) | $179 | N/A | N/A |
| Earnings per Share (Diluted) | $7.58 | N/A | N/A |
| Beta (Stock Volatility) | 0.40 | N/A | N/A |
Dishman Carbogen Amcis Ltd. vs Til Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | -2.38% | -2.24% | -7.21% | 9.02% | -19.76% | -29.73% |
| Til Ltd. | 0.00% | 4.38% | -8.06% | -7.35% | -32.56% | -32.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | -33.95% | 46.77% | -6.77% | 33.46% | 290.77% | 118.12% |
| Til Ltd. | -49.35% | 46.85% | 2.94% | -31.20% | -58.85% | -1.91% |
Performance & Financial Health Analysis: Dishman Carbogen Amcis Ltd. vs Til Ltd.
| Metric | DCAL | TIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹26.50B | N/A |
| Market Cap Category | Small cap | N/A |
| 10 Day Avg. Volume | 337,264 | N/A |
| 90 Day Avg. Volume | 517,904 | N/A |
| Last Close | ₹180.24 | ₹181.95 |
| 52 Week Range | ₹128.50 - ₹321.95 | ₹161.25 - ₹409.00 |
| % from 52W High | -44.02% | -55.51% |
| All-Time High | ₹396.40 (Jan 22, 2018) | ₹864.00 (Jul 27, 2015) |
| % from All-Time High | -54.53% | -78.94% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | N/A |
| Quarterly Earnings Growth | -0.09% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.10% |
| Operating Margin (TTM) | 0.04% | N/A |
| Return on Equity (TTM) | 0.00% | N/A |
| Debt to Equity (MRQ) | 40.20 | N/A |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹405.67 | N/A |
| Cash per Share (MRQ) | ₹40.41 | N/A |
| Operating Cash Flow (TTM) | ₹-199,700,000 | N/A |
| Levered Free Cash Flow (TTM) | ₹32.40M | N/A |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Dishman Carbogen Amcis Ltd. vs Til Ltd.
| Metric | DCAL (Apr 26, 2026) | TIL (Jul 16, 2025) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.30 | 26.18 |
| Forward P/E | 13.52 | 26.10 |
| PEG Ratio | -0.16 | 2.42 |
| Price to Sales (TTM) | 0.95 | 9.94 |
| Price to Book (MRQ) | 0.42 | 3.22 |
| Market Capitalization | ||
| Market Capitalization | ₹26.50B | ₹111.56B |
| Enterprise Value | ₹46.55B | ₹104.86B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.66 | 1.93 |
| Enterprise to EBITDA | 9.62 | 18.17 |
| Risk & Other Metrics | ||
| Beta | 0.40 | N/A |
| Book Value per Share (MRQ) | ₹405.67 | N/A |
Financial Statements Comparison: Dishman Carbogen Amcis Ltd. vs Til Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DCAL (2025) | TIL (2025) |
|---|---|---|
| Revenue/Sales | 26.42B | 3.15B |
| Cost of Goods Sold | 5.26B | 2.03B |
| COGS % of Revenue | 19.9% | 64.5% |
| Gross Profit | 21.16B | 1.12B |
| Gross Margin | 80.1% | 35.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.46B | 54.40M |
| Operating Margin | 5.5% | 1.7% |
| EBITDA | 4.83B | 402.00M |
| EBITDA Margin | 18.3% | 12.8% |
| Pre-Tax Income | 193.10M | 41.50M |
| Pre-Tax Income % of Revenue | 0.7% | 1.3% |
| Income Tax | 160.70M | 12.90M |
| Income Tax % of Revenue | 0.6% | 0.4% |
| Net Income (Profit) | 32.40M | 28.60M |
| Profit Margin | 0.1% | 0.9% |
Balance Sheet & Liquidity Metrics
| Metric | DCAL (2025) | TIL (2025) |
|---|---|---|
| Cash & Equivalents | 2.86B | 5.90M |
| Total Current Assets | 22.00B | 3.19B |
| Total Current Assets % of Revenue | 83.3% | 101.1% |
| Total Current Liabilities | 19.25B | 2.59B |
| Total Current Liabilities % of Revenue | 72.9% | 82.2% |
| Long-Term Debt | 13.90B | 1.73B |
| Long-Term Debt % of Revenue | 52.6% | 54.9% |
| Total Shareholders Equity | 58.32B | 823.60M |
| Retained Earnings | 2.13B | N/A |
| Retained Earnings % of Revenue | 8.1% | 0.0% |
| Property, Plant & Equipment | 10.27B | 985.90M |
Cash Flow Statement Comparison
| Metric | DCAL (2025) | TIL (2025) |
|---|---|---|
| Operating Cash Flow | -199.70M | -876.70M |
| Operating Cash Flow % of Revenue | -0.8% | -27.8% |
| Capital Expenditures | -2.15B | -31.20M |
| Free Cash Flow | 1.58B | -1.37B |
| FCF Margin | 6.0% | -43.3% |
| Debt Repayment | -1.10B | -757.50M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DCAL | TIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 156.78M | N/A |
| Float Shares | 54.95M | N/A |
| % Held by Insiders | 69.30% | N/A |
| % Held by Institutions | 2.41% | N/A |
| % Held by Public | 28.29% | N/A |
Dividend Analysis & Yield Comparison: Dishman Carbogen Amcis Ltd. vs Til Ltd.
| Metric | DCAL | TIL |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |